Filter News
Area of Research
- (-) Materials (88)
- (-) National Security (30)
- (-) Supercomputing (57)
- Advanced Manufacturing (11)
- Biology and Environment (46)
- Biology and Soft Matter (1)
- Clean Energy (98)
- Computational Biology (1)
- Computer Science (2)
- Fusion and Fission (12)
- Fusion Energy (1)
- Materials for Computing (9)
- Neutron Science (21)
- Nuclear Science and Technology (7)
- Quantum information Science (3)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (22)
- (-) Artificial Intelligence (44)
- (-) Chemical Sciences (27)
- (-) Cybersecurity (21)
- (-) Microscopy (20)
- (-) Physics (30)
- (-) Sustainable Energy (15)
- Advanced Reactors (3)
- Big Data (16)
- Bioenergy (19)
- Biology (16)
- Biomedical (15)
- Biotechnology (3)
- Buildings (6)
- Clean Water (2)
- Climate Change (22)
- Composites (5)
- Computer Science (87)
- Coronavirus (15)
- Critical Materials (8)
- Decarbonization (10)
- Energy Storage (27)
- Environment (32)
- Exascale Computing (19)
- Frontier (25)
- Fusion (5)
- Grid (12)
- High-Performance Computing (35)
- Isotopes (11)
- ITER (1)
- Machine Learning (21)
- Materials (63)
- Materials Science (57)
- Mathematics (1)
- Molten Salt (2)
- Nanotechnology (32)
- National Security (34)
- Net Zero (2)
- Neutron Science (37)
- Nuclear Energy (17)
- Partnerships (14)
- Polymers (10)
- Quantum Computing (16)
- Quantum Science (28)
- Renewable Energy (1)
- Security (13)
- Simulation (11)
- Software (1)
- Space Exploration (3)
- Summit (35)
- Transformational Challenge Reactor (3)
- Transportation (13)
Media Contacts
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
A modern, healthy transportation system is vital to the nation’s economic security and the American standard of living. The U.S. Department of Energy’s Oak Ridge National Laboratory (ORNL) is engaged in a broad portfolio of scientific research for improved mobility
Artificial intelligence (AI) techniques have the potential to support medical decision-making, from diagnosing diseases to prescribing treatments. But to prioritize patient safety, researchers and practitioners must first ensure such methods are accurate.
Materials scientists, electrical engineers, computer scientists, and other members of the neuromorphic computing community from industry, academia, and government agencies gathered in downtown Knoxville July 23–25 to talk about what comes next in
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
A team of scientists led by Oak Ridge National Laboratory have discovered the specific gene that controls an important symbiotic relationship between plants and soil fungi, and successfully facilitated the symbiosis in a plant that
In the shifting landscape of global manufacturing, American ingenuity is once again giving U.S companies an edge with radical productivity improvements as a result of advanced materials and robotic systems developed at the Department of Energy’s Manufacturing Demonstration Facility (MDF) at Oak Ridge National Laboratory.
Using artificial neural networks designed to emulate the inner workings of the human brain, deep-learning algorithms deftly peruse and analyze large quantities of data. Applying this technique to science problems can help unearth historically elusive solutions.
OAK RIDGE, Tenn., March 11, 2019—An international collaboration including scientists at the Department of Energy’s Oak Ridge National Laboratory solved a 50-year-old puzzle that explains why beta decays of atomic nuclei
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.